ApprovalTrail

Approval · Notice of Compliance 7832 · 2006

SECTRAL: Notice of Compliance 7832

Issued March 17, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7832
Date
March 17, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antihypertensive and anti-anginal agent

Products in this notice

BrandDINStatus today
SECTRAL01926543Cancelled Post Market
SECTRAL01926551Cancelled Post Market
SECTRAL01926578Cancelled Post Market

Medicinal ingredients